CClinicalTrials.gg
CompletedNCT02708212Updated Feb 1, 2017Results posted

Optimal Procedural Sequence in Same-day Bidirectional Endoscopy: A Prospective Randomized Controlled Study

An interventional study of EGD and colonoscopy in Endoscopy and Moderate Sedation, sponsored by Evergreen General Hospital, Taiwan. Completed. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2017-02-01.

Sponsored by Evergreen General Hospital, Taiwan · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
121
Allocation
Randomized
Ages
20 Years to 75 Years
Sex
All
01

Study summary

The Same-day bidirectional endoscopy (BDE) is commonly used in clinical practice. However, the optimal sequence of performing a same-day BDE has not been well-established.The primary aims of this study are to compare the sedative doses and patient discomfort between the study groups who received a colonoscopy followed by and EGD (colonoscopy-EGD), or an EGD followed by a colonoscopy (EGD-colonoscopy) during a same-day BDE. The secondary aim is to assess colonoscopy performance, including the cecal intubation time and adenoma detection rate between the two endoscopic sequences.

02

Conditions studied

  • Endoscopy
  • Moderate Sedation
03

In context

Lead sponsor

Evergreen General Hospital, Taiwan is the lead sponsor of 10 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Outpatients, aged 20 to 75 years, who are scheduled for same-day bidirectional endoscopy examination for any indication are invited to participate in the study.

Exclusion criteria

Exclusion Criteria:

    1. previous gastrectomy or colectomy 2. inadequate bowel preparation, 3. obstructive lesions of the colon 4. severe colitis, gastrointestinal bleeding 5. allergy to fentanyl or midazolam 6. American Society of Anesthesiology (ASA) classification of physical status grade 3 or higher, 7. mental retardation 8. regular use of narcotics 9. pregnancy 10. refusal to provide a written informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
121 participants (actual)

Study arms

  • Active comparator
    EGD-colonoscopy group

    In this group, patients receiving an EGD followed by a colonoscopy during a same-day bidirectional endoscopy. Patients receive moderate conscious sedation with fentanyl and midazolam for the procedures. Gastric polypectomy will be provided when gastric polyps are found during an EGD study. Colon polypectomy will be provided when colon polyps are found during a colonoscopy study. Patients' heart rate, respiratory rate, blood pressure, and oxygen saturation will be recorded every 60 seconds during the endoscopic examinations. Patients' tolerability to EGD and colonoscopy examinations will be scaled by patients and endoscopists after the completion of the examinations. Aldrete scores are recorded15 minutes and 25 minutes after entering the recovery room. The recovery time will also be recorded.

    Procedure: EGD and colonoscopy

  • Active comparator
    Colonoscopy-EGD group

    In this study group, patients receive a colonoscopy followed by an EGD during a same-day bidirectional endoscopy. Patients receive moderate conscious sedation with fentanyl and midazolam for the procedures. Colon polypectomy will be provided when colon polyps are found during a colonoscopy study. Gastric polypectomy will be provided when gastric polyps are found during an EGD study. Patients' heart rate, respiratory rate, blood pressure, and oxygen saturation will be recorded every 60 seconds during the endoscopic examinations. Patients' tolerability to colonoscopy and EGD examinations will be scaled by patients and endoscopists after the completion of the examinations. Aldrete scores are recorded15 minutes and 25 minutes after entering the recovery room. The recovery time will also be recorded.

    Procedure: EGD and colonoscopy

Interventions

  • ProcedureEGD and colonoscopy

    Cold forceps biopsy, cold snare polypectomy, and/or hot snare polypectomy will be performed for stomach and/or colon polyps during EGD and colonoscopy examinations will be performed whenever indicated.

06

What researchers measure

Primary outcomes

  1. Sedative Doses of Fentanyl

    During bidirectional endoscopy, the total doses of fentanyl were recorded and compared between the two study groups.

    Time frame: On the day of endoscopic procedures.

  2. Sedative Doses of Midazolam

    During bidirectional endoscopy, the total doses of midazolam were recorded and compared between the two study groups.

    Time frame: On the day of bidirectional endoscopy procedures

Secondary outcomes

  1. Overall Duration of BDE Examinations

    The overall duration of both EGD and colonoscopy examinations was recorded and compared.

    Time frame: On the day of bidirectional endoscopy

07

Results

Posted Dec 2, 2016

Participant flow

Total 129 patients were invited to participate in the study from April to July 2016, and 8 patients were excluded. Finally, 121 patients were recruited for the study which was performed in a community hospital (Evergreen General Hospital). One patient in the EGD-colonoscopy was further excluded from final analysis due to poor bowel preparation.

Participant flow — Overall Study
MilestoneEGD-colonoscopy GroupColonoscopy-EGD Group
Started6060
Completed6060
Not completed00

Outcome measures

PrimarySedative Doses of Fentanyl

During bidirectional endoscopy, the total doses of fentanyl were recorded and compared between the two study groups.

Time frame:
On the day of endoscopic procedures.
Reported as:
Mean · mcg/kg
Sedative Doses of Fentanyl
mcg/kgEGD-colonoscopy GroupColonoscopy-EGD Group
Sedative Doses of Fentanyl1.09 ± 0.421.28 ± 0.31
Statistical analysis
  • EGD-colonoscopy Group vs Colonoscopy-EGD Group · t-test, 2 sided · p = <0.0001
PrimarySedative Doses of Midazolam

During bidirectional endoscopy, the total doses of midazolam were recorded and compared between the two study groups.

Time frame:
On the day of bidirectional endoscopy procedures
Reported as:
Mean · mg/kg
Sedative Doses of Midazolam
mg/kgEGD-colonoscopy GroupColonoscopy-EGD Group
Sedative Doses of Midazolam0.08 ± 0.030.10 ± 0.02
Statistical analysis
  • EGD-colonoscopy Group · t-test, 2 sided · p = 0.0012
SecondaryOverall Duration of BDE Examinations

The overall duration of both EGD and colonoscopy examinations was recorded and compared.

Time frame:
On the day of bidirectional endoscopy
Reported as:
Mean · minutes
Overall Duration of BDE Examinations
minutesEGD-colonoscopy GroupColonoscopy-EGD Group
Overall Duration of BDE Examinations32.7 ± 9.933.3 ± 7.5
Statistical analysis
  • EGD-colonoscopy Group vs Colonoscopy-EGD Group · t-test, 2 sided · p = 0.6967

Adverse events

Collected over From the start of bidirectional endoscopy to one hour after the completion of the bidirectional endoscopy.. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
EGD-colonoscopy Group—0/60 (0%)19/60 (31.7%)
Colonoscopy-EGD Group—0/60 (0%)20/60 (33.3%)
Most frequent other events
Most frequent other events
EventEGD-colonoscopy GroupColonoscopy-EGD Group
Transient hypotensionVascular disorders19/6020/60

Baseline characteristics

Total 120 patients were randomly assigned to EGD-colonoscopy group (n=60) and colonoscopy-EGD group (n=60).

Age, Continuous
Age, Continuous(years)EGD-colonoscopy GroupColonoscopy-EGD GroupTotal
Mean54.5 ± 11.152.9 ± 12.753.7 ± 11.9
Gender
Gender(Participants)EGD-colonoscopy GroupColonoscopy-EGD GroupTotal
Female343064
Male263056
Region of Enrollment
Region of Enrollment(participants)EGD-colonoscopy GroupColonoscopy-EGD GroupTotal
Taiwan6060120
08

Study locations

No study locations are listed for this record.

09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 1, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02708212
Lead sponsor
Evergreen General Hospital, Taiwan
Responsible party
Chi-Liang Cheng (M.D., Evergreen General Hospital, Taiwan) — Principal investigator
First posted
Mar 15, 2016
Start date
Apr 2016
Primary completion
Jul 2016
Completion
Jul 2016
Results posted
Dec 2, 2016
Last update
Feb 1, 2017

Study contacts

Chi-Liang Cheng, MD
principal investigator · Evergreen General Hospital, Taiwan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion